Yourgene Health Share Price (YGEN)

[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 14.75 3,582,084 07:39:39
Bid Price Offer Price High Price Low Price Open Price
14.50 15.00 14.75 14.75 14.75
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18.29 -12.01 -1.80 107
Last Trade Time Trade Type Trade Size Trade Price Currency
16:05:50 O 1,180,832 14.625 GBX
Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Motif Bio (MTFB), Bermele (BERM)

Yourgene Health (YGEN) Latest News

Yourgene Health News

Date Time Source Headline
15/9/202107:00UKREGYourgene Health PLC Share option awards
10/9/202108:16DJNYourgene Health Wins GBP34.1 Million Covid-19 Testing Governmental Contract
10/9/202107:00UKREGYourgene Health PLC Re DHSC contract to support COVID-19 surge testing
01/9/202114:33ALNCTRADING UPDATES: Trifast buys in US; Eckoh trading meets expectations
01/9/202107:00RNSNONYourgene Health PLC ISO 15189:2012 accreditation received
19/8/202112:50ALNCTRADING UPDATES: Resolute books hefty impairments; tinyBuild buys
19/8/202112:33DJNYourgene Health Gets UK Covid-19 Testing Contract
19/8/202112:04UKREGYourgene Health PLC COVID-19 Surge testing contract
11/8/202117:29ALNCEARNINGS UPDATES: Woodbois reports narrowed loss; Goodwin profit rises
11/8/202107:01UKREGYourgene Health PLC Earn-out Milestone, Issue of Equity & TVR
More Yourgene Health News
Yourgene Health Investors    Yourgene Health Takeover Rumours

Yourgene Health (YGEN) Discussions and Chat

Yourgene Health Forums and Chat

Date Time Title Posts
21/9/202112:43YGEN2,077
20/5/202007:42YourGene to Infinity2,121
04/5/202008:06Partnership with Novacyt 2
30/3/202008:20Yourgene Health at the UK Investor Show3

Add a New Thread

Yourgene Health (YGEN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Yourgene Health trades in real-time

Yourgene Health (YGEN) Top Chat Posts

DateSubject
25/9/2021
09:20		Yourgene Health Daily Update: Yourgene Health Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker YGEN. The last closing price for Yourgene Health was 14.75p.
Yourgene Health Plc has a 4 week average price of 14.25p and a 12 week average price of 11.85p.
The 1 year high share price is 21.25p while the 1 year low share price is currently 11.63p.
There are currently 723,780,306 shares in issue and the average daily traded volume is 792,013 shares. The market capitalisation of Yourgene Health Plc is £106,757,595.14.
Read Full Thread
Reply
13/9/2021
11:13		the abbot: Twix, your post was disingenuous and chose to use only the last line to reinforce your own point and not the point of the message from Ron which was obviously to show that the PCR focus will be on positive LFT tests, rather than a scattergun approach. You are also wrong, it will not hit testing volumes hard for yourgene and here is why. 1. All PCR tests conducted for returning travellers are currently conducted outside of the UK in the country where they are coming from thus will have no impact 2. The government is using this partly to get rid of the fly by night cowboys, the respected ISO accredited companies will pickup further work from the removal of these other companies. 3. All positive LFT's will be confirmed by a PCR to avoid quarantine or loss of working days due to the lower accuracy of the LFT test. The gov is using LFT for speed of delivery, easy of use and where PCR is used for test and trace, lower cost. However, as the LFT's are cheaper and easier to get hold off, there will be more tests conducted, thus proportionally more positive tests found that need to be PCR'ed. The drop in the share price today is a blip and temporary due to PI misunderstanding and this will be proven on the day of the AGM when Lyn presents the trading figures and outlook. Indeed it has already been reported by Davand on LSE that the Gov are already in some ways backtracking on what they have said regarding PCR. Bottom line is you cannot get rid of a confirmatory test in place of an inaccurate one.
Read Full Thread
Follow
Reply
13/9/2021
10:42		twix386: No I haven'tI posted the concluding point rather than the full post. If that's out of context that's worth a mention but I don't think it is. The emphasise was on no worries but rather it will hit testing volumes hard and as usual poster sought to incorrectly minimise the core take away from the headline issue unlike the share price which dropped.
Read Full Thread
Follow
Reply
03/8/2021
13:05		apad: I hope so Ygen Nap. I have given up trying to explain the share price performance. Sometimes one has to accept that logic has flown and there is no point trying to explain the trends. Anyroadup, I am significantly committed and sacrificing a goat for next week's news. GLA apad
Read Full Thread
Follow
Reply
26/7/2021
19:45		phatomtraider: It is funny when rampers who post ad nauseum find a contrarian single post enough qualification to consider a person a troll, or enough to shake their views in a Company. If you believe in the Company, BoD, CEO and product and strategy then sod what anyone says on a BB. You must be pretty unconvinced on your investment if a single post has shaken your confidence. Who are you trying to convince. On the aside it is equally funny when aliases are taken, but the posting style does not @-; I don't believe that even YGEN's leaking ship of an Investment Team had revealed who had sold the Options, but then BB readers can work it out for themselves. You just have to go through the Options Award RNS history and see who has been awarded Options at 10.25 pence. Rampers have been suggesting that the Results will reveal a boom. Could be. However the point that I was making was that the exercise of Options on the 17th June (when the share price was @ circa 13.25p) indicated a pessimistic attitude within the Company. If you think that the BoD, each year, have been awarding themselves a few millions worth of Options then you would have hoped that that they would have been incentivised to make the share price appreciate more than they have. If they do not care of the sp, and just want to get on with the day job, then stop awarding yourselves Options at pace. Exercising Options @10.25p when the share price is @13.25p is hardly a vote of confidence. Trawl through the Options RNS and you get to the 03rd June 2019 RNS. Where you can see who were awarded Options @10.25p. Lyn Rees: 4,000,000 Barry Hextall: 400,000 Bill Chang: 400,000 Hayden Jeffreys: 2,400,000 So if it was not Barry Hextall, then who else would you prefer it to be? The current CEO? Remember the 17th June 2021 gave notice of two exercise of options of 400,000 new ordinary shares in the Company at an exercise price of 10 pence per share and over 150,000 new ordinary shares in the Company at an exercise price of 10.25 pence per share, as above, by two employees. So when you look at who got Options @10p you can only find Dr Stephen Little 10,555,984 options at that exercise price on 2 October 2014 RNS. Would you prefer then the past CEO? SP weakness has been dire and persistent since the beginning of the year (Feb RNS) when the 1st warning signs were given , with no good news able to shift trajectory downwards as if something is known. Lots of good posters tried to give warnings, only to be replaced by paid rampers and aliases. Not much time to go now. If I was a betting man, I would say that with AR's track record another acquisitive placing is coming up, as it has been some time since the Coastal Genomics purchase. On that note the share price weakness could be indicating a 2nd element of the Earn Out Fee for Coastal Genomics that saw 14,945,689 added to the shares in circulation. My reading is that LR has paid too much for these acquisitions which are not resulting in revenue expectations he promised to shareholders, hence some II's dumping in the face of share drag and year-on-year "jam-tomorrow" expectations. At some point CEO's need to deliver value to their shareholders, and LR's largess seems to be more at the expense of existing PIs and LTHs. Just call it a day and sell the freaking Company, and put your shareholders out of their year-on-year misery.
Read Full Thread
Follow
Reply
07/7/2021
19:36		ngen yap: YGEN supplies all the test kits ie Clarigene for MHC lab tests and also perform overspill work under MHC-Boots contract. If MHC registered £2M revenue in 2 months ie May and June alone, then I expect YGEN numbers to be very encouraging too. We also have NPH, Recova, CityDoc etc as channels! Just wish the company will say something to help improve the sentiments and share price! Come on Lynn!
Read Full Thread
Follow
Reply
28/4/2021
12:43		phatomtraider: Are you still getting amused? If BMD is getting his contract wins correct, that means someone is leaking it to him. So you are then talking of someone at Director level who has inside knowledge of the Contract Pipeline. Why would a Director leak this to BMD and others? To aid them as a tipster? Provide PIs an inside track before the IIs? Realistically it was to facilitate a pump and dump. PIs alone do not account for a 20%+ fall in the share price despite successive RNS, on potential transformational contracts. And I do not think the Seller is expecting a quick bounce from TU, otherwise just release the TU and get over it, quick sharp. PI's should be angry here, but not against singular contrary posts against the rampfest to facilitate a pump and dump to facilitate a better price for the Seller. LR has failed to add share price value here despite the years and Options given. Whether it be organic growth, price paid for acquisitions, expensive earn out fees, false-start of IONA Nx roll-out and the lost opportunity of the last year where the wrong strategy was clearly chosen. With sub-13p expected by next week, PIs should really be asking when LR will actually deliver share price value for them having taken over when the share price was 16.5p.
Read Full Thread
Follow
Reply
08/4/2021
10:49		phatomtraider: As before play the ball, not the player. For LTHs you chaps surprisingly post absolutely nothing in terms of scientific interest, no reference to facts, figures, lab capacity or contractual assessments. Instead you personalise any assessment of the poor performance of the share price and the Company. For what reason, given that the Directors had already misled investors here on a few occasions last year? 1 poster cannot affect a stock of 721m+ shares. Especially when contrasted to BB rampers and the Twitter pump and dump brigade. So get over yourselves and frankly grow up. Or better yet, rather than sending lazy 1-line ramping posts degrading posters at a personal level when they reference RNS in their posts, perhaps you know post something positive about the Company? I would look more at the trades that happened yesterday to understand why you are flatlining, rather than attribute my posting prowess. You were warned from circa 20th March onwards when the share price was closer to 17p that there would be a slide here towards the Results. The share price performance has already proved one of us right. Just let the Seller out, or ramp to give them a better price. Your choice.
Read Full Thread
Follow
Reply
07/4/2021
17:06		phatomtraider: Christ it is pathetic to even think that a poster on a BB, averaging a solitary post a day, can influence the share price of a share with 721m shares. The share price will do what the share price will do regardless of my solitary posts, or my holdings. Cannot see the calls for balanced and informed posts stopping those ramping on this BB, Twitter or LSE. So please. You were informed when the share price was higher that a repeat of what happened last year with the sale of the Euciligene Directors shares and Options was going to happen again. If it hasn't then how can you explain the lacklustre share price if someone is not selling in the background, and into any rise? Rather than ramping to give these Directors a better price, just buy after the Results. I mean duh!?
Read Full Thread
Follow
Reply
25/3/2021
10:56		phatomtraider: Options exercised will add 2,553,333 new ordinary shares on or around 26 March 2021. Exercise price sub-10p so I would expect them to be sold pre-Results as not expecting a spike especially after given GDR results today. Massively inflated share price to non-existent sales in PCR space. Mugs following the dodgy chartists and paid-for rampers will just be propping up the share price so that the Directors can dump their shares pre-Results from tomorrow onwards.
Read Full Thread
Follow
Reply
07/2/2021
10:19		apad: I bought YGEN as a recovery play before the pandemic after they stopped litigation as a recovery play. The pandemic has put this on hold and the corvid activity is a patch to keep the company going. YGEN's revenue per employee is £126k and 5 years of revenue will buy the company. These are not good figures and there are other poor metrics that demonstrate its current dilemma. I wouldn't buy shares now, but have decided to hold as a survivability play. Nevertheless the share price, even after the recent fall, is not attractive - given the risks and the company metrics. I am expecting share price weakness to continue until (unless) they can report revenue growth well above the last FY at 5%. Good luck to all of us stuck in this potential energy well - both the optimistic and the pessimistic 😊 apad
Read Full Thread
Follow
Reply
Yourgene Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
YGEN
Yourgene H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210925 16:53:53